510(k) · Cleared
ClearedAview Cac
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Coreline Soft Co., Ltd. · QIH Automated Radiological Image Processing Software
Cleared on Mar 29, 2024 as substantially equivalent to K214036 (Coreline Soft Co., Ltd., 2022) after a 183-day review. Its family tree reaches back 11 generations to 1995. 2 later devices descend from it.
- Decided
- Mar 29, 2024
- Review
- 183 days
- Class
- Class II
- Product code
- QIH
- Recalls
- None
- Predicates
- 1
Its longest line of descent runs back 11 generations to K954355 (1995). 15 ancestors in all. 2 later devices descend from it, 2 citing it directly.
- Root · 11 generations backK954355 Advantage Windows 3D with Navigator OptionGeneral Electric Co. · 1995
- 7 generations between
- 3 generations backK171199 AVIEWCoreline Soft Co., Ltd. · 2018
- 2 generations backK200714 AVIEWCoreline Soft Co., Ltd. · 2020
- 1 generation backK214036 AVIEWCoreline Soft Co., Ltd. · 2022
- This deviceK233211 Aview CacCoreline Soft Co., Ltd. · 2024
- Descendant · cites it directly · 0 of its ownK250288 TeraRecon Cardiovascular.Calcification.CTTerarecon,Inc. · 2025
- Descendant · cites it directly · 0 of its ownK243696 Aview CacCoreline Soft Co., Ltd. · 2025
Show all 11 generations
- Root · 11 generations backK954355 Advantage Windows 3D with Navigator OptionGeneral Electric Co. · 1995
- 10 generations backK974715 Advantage 3D XRGE Medical Systems · 1998
- 9 generations backK984634 3D-AngioSiemens Medical Corp. · 1999
- 8 generations backK011447 IN Space 3DSiemens Medical Solutions USA, Inc. · 2001
- 7 generations backK043469 Syngo Inspace 4DSiemens AG Medical Solutions · 2005
- 6 generations backK071513 Inspace 4D Software Package with Extended FunctionalitySiemens Medical Solutions · 2007
- 5 generations backK083227 Vida Pulmonary Workstation 2 (PW2)Vida Diagnostics, Inc. · 2008
- 4 generations backK151919 Vitrea CT Lung Density Analysis SoftwareVital Images, Inc. · 2015
- 3 generations backK171199 AVIEWCoreline Soft Co., Ltd. · 2018
- 2 generations backK200714 AVIEWCoreline Soft Co., Ltd. · 2020
- 1 generation backK214036 AVIEWCoreline Soft Co., Ltd. · 2022
- This deviceK233211 Aview CacCoreline Soft Co., Ltd. · 2024
Most influential descendants
Showing 2 of 2 · See allView FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −11 | K954355 | Advantage Windows 3D with Navigator Option | General Electric Co. | 1995 | — |
| −10 | K974715 | Advantage 3D XR | GE Medical Systems | 1998 | — |
| −9 | K984634 | 3D-Angio | Siemens Medical Corp. | 1999 | — |
| −8 | K011447 | IN Space 3D | Siemens Medical Solutions USA, Inc. | 2001 | — |
| −7 | K043469 | Syngo Inspace 4D | Siemens AG Medical Solutions | 2005 | — |
| −6 | K071513 | Inspace 4D Software Package with Extended Functionality | Siemens Medical Solutions | 2007 | — |
| −5 | K083227 | Vida Pulmonary Workstation 2 (PW2) | Vida Diagnostics, Inc. | 2008 | — |
| −4 | K151919 | Vitrea CT Lung Density Analysis Software | Vital Images, Inc. | 2015 | — |
| −3 | K171199 | AVIEW | Coreline Soft Co., Ltd. | 2018 | — |
| −2 | K200714 | AVIEW | Coreline Soft Co., Ltd. | 2020 | — |
| −1 | K214036 | AVIEW | Coreline Soft Co., Ltd. | 2022 | — |
| 0 (this device) | K233211 | Aview Cac | Coreline Soft Co., Ltd. | 2024 | — |
| +1 | K250288 | TeraRecon Cardiovascular.Calcification.CT | Terarecon,Inc. | 2025 | — |
| +1 | K243696 | Aview Cac | Coreline Soft Co., Ltd. | 2025 | — |
Other ancestors by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 1996 | 1 | 0 |
| 1998 | 2 | 0 |
| 2000 | 1 | 0 |
Descendants by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 2025 | 2 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in QIH? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new QIH device
- #1 K213998 cvi42 Auto Imaging Software Applicationscore 23.5 · 7 generations · no Class I recall
- #2 Held for the reportin the report
- #3 Held for the reportin the report
What was it cleared against? (1)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K214036 | AVIEWSummary page 4…n Name: Medical Image Management and Processing System (21CFR 892.2050) Regulatory Class: II Product Code: QIH, JAK 3 PREDICATE DEVICE AVIEW by Coraline Soft Co., Ltd. (K214036) Name of Device: AVIEW Common or Usual Name: Image Processing Software Classification Name: Medical Image Management and Process… | 2022 |
| † | K210085 | HealthCCSng | 2021 |
What descends from it? (2)
2 later devices cite it directly; ranked here by how many devices descend from each in turn.
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
- The line of descent spans 29 years and passes through 9 companies; a new generation was cleared every 2.4 years on median.
- 1 of the 15 ancestors has a recall of any class.
- Of its descendants, K250288 (Terarecon,Inc., 2025) has gone furthest, with 0 descendants of its own.
- 1 other device also cites its predicate K214036.
How does its category compare?
All QIH devicesQIH Automated Radiological Image Processing Software: FDA decisions, review times, recalls and adverse event reports over 20 years. 2024, this device’s year, is highlighted.
FDA decisions per year · QIH
94in 2025
2026 to Oct 25, outlined.
Median 510(k) review, days · QIH
150in 2025
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · QIH
1so far in 2026, the most since 2007
Class I (0 since 2007) Class II/III not classified
Adverse event reports per year · QIH
4in 2025
MAUDE reports naming product code QIH, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 0 | — | 0 | 0 |
| 2008 | 0 | — | 0 | 0 |
| 2009 | 0 | — | 0 | 0 |
| 2010 | 0 | — | 0 | 0 |
| 2011 | 0 | — | 0 | 0 |
| 2012 | 0 | — | 0 | 0 |
| 2013 | 0 | — | 0 | 0 |
| 2014 | 0 | — | 0 | 0 |
| 2015 | 0 | — | 0 | 0 |
| 2016 | 0 | — | 0 | 0 |
| 2017 | 0 | — | 0 | 0 |
| 2018 | 0 | — | 0 | 0 |
| 2019 | 2 | — | 0 | 0 |
| 2020 | 11 | 145 | 0 | 0 |
| 2021 | 19 | 125 | 0 | 0 |
| 2022 | 25 | 134 | 0 | 0 |
| 2023 | 45 | 151 | 0 | 0 |
| 2024 | 64 | 141 | 0 | 2 |
| 2025 | 94 | 150 | 0 | 4 |
| 2026 | 78 | 130 | 1 | — |
What is it indicated for?
A VIEW CAC provides quantitative analysis of calcified plaques in the coronary arteries using non-contrast/non-gated Chest er scans. It enables the calculation of the Agatston score for coronary artery calcification, segmenting and evaluating the right coronary artery and left coronary artery. Also provide risk stratification based on calcium score, gender, and age, offering percentile-based risk categories by established guidelines. Designed for…
Read the full statement (145 words)
A VIEW CAC provides quantitative analysis of calcified plaques in the coronary arteries using non-contrast/non-gated Chest er scans. It enables the calculation of the Agatston score for coronary artery calcification, segmenting and evaluating the right coronary artery and left coronary artery. Also provide risk stratification based on calcium score, gender, and age, offering percentile-based risk categories by established guidelines. Designed for healthcare professionals, including radiologists and cardiologists, AVIEW CAC supports storing, transferring, inquiring, and displaying CT data sets on-premises, facilitating access through mobile devices and Chrome browsers. AVIEW CAC analyzes existing non-contrast/non-gated Chest CT studies that include the heart of adult patients above the age of 40. Also, the device's use should be limited to er scans acquired on General Electric (GE) or its subsidiaries (e.g., GE Healthcare) equipment. Use of the device with CT scans from other manufacturers has not been validated or recommended.
Indications for use as stated in the FDA summary.
https://510kreport.com/device/K233211 · printed Nov 6, 2026
Cite this page
510(k) Report. “K233211: Aview Cac.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K233211
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026